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Acne vulgaris is characterized by excess sebum production, and apart from all-trans retinoic acid (atRA) or 13-cis
retinoic acid (13-cisRA), there are few effective agents for acne therapy that directly suppresses sebaceous
lipogenesis. In this study, we demonstrated that topical application of a citrus polymethoxy flavonoid, nobiletin,
to hamster auricles decreased skin surface triacylglycerols (TG) level and the size of sebaceous glands along
with inhibition of diacylglycerol acyltransferase (DGAT)-dependent TG synthesis and sebocyte proliferation.
The inhibitory actions were similar to that observed with atRA and 13-cisRA in hamster sebocytes. The
antilipogenic and antiproliferative actions of nobiletin were also reproduced in UVB (5.4 kJ/m2)-irradiated
hamsters, which showed aberrant enhancement of sebum accumulation and sebaceous enlargement.
Furthermore, nobiletin, but not 13-cisRA, augmented sebum excretion along with increases in intracellular
cAMP level, protein kinase A (PKA) activation, and apoptosis-independent phosphatidylserine (PS) externaliza-
tion in cell membrane. These phenomena were reproduced by forskolin and inhibited by a PKA inhibitor, H-89.
These results provide early evidence that nobiletin is an effective candidate for acne therapy through
mechanisms that include the inhibition of DGAT-dependent TG synthesis and sebocyte proliferation, and the
progression of apoptosis-independent and PS-externalization-dependent sebum excretion by PKA activation.
Journal of Investigative Dermatology (2007) 127, 2740–2748; doi:10.1038/sj.jid.5700927; published online 28 June 2007
INTRODUCTION
Acne vulgaris is an inflammatory disease in sebaceous glands
and pilosebaceous units in the skin, which often occurs
in pubertal young individuals, under androgen influ-
ence (Bojar and Holland, 2004). Acne is characterized by:
(i) excess sebum production and enlargement of sebaceous
glands that are dependent on androgen; (ii) comedogenesis
that is closely associated with hypercornification of the
follicular wall epidermis; and (iii) local inflammatory events
such as an increase in levels of proinflammatory cytokines
and the formation of papules and pustules (Pawin et al.,
2004). In addition, Propionibacterium acnes (P. acnes),
a Gram-positive anaerobe microbial species, is considered
to play a principal role in the development of acne vulgaris
by causing inflammation and hypercornification in ductal
and infundibular epidermis (Bojar and Holland, 2004).
Retinoic acids such as tretinoin (all-trans retinoic acid
(atRA)) and isotretinoin (13-cis retinoic acid (13-cisRA)) have
been topically and/or systemically used for acne therapy
(Krautheim and Gollnick, 2004; Chivot, 2005). Both atRA
and 13-cisRA have caused a decrease of sebum production
and sebaceous gland enlargement by inhibiting lipogenesis
and cell proliferation in humans, rats, and hamsters
(Zouboulis et al., 1991; Kim et al., 2000; Sato et al., 2001;
Nelson et al., 2006). In addition, topical and/or systemic
application of antibiotics such as erythromycin, tetracycline,
and doxycycline has been reported to be effective in the
treatment of acne, because they inhibit the proliferation of
P. acnes in the follicles and thereby decrease the level of
free-fatty acids on the skin surface (Toyoda and Morohashi,
1998; Krautheim and Gollnick, 2004; Sapadin and Fleisch-
majer, 2006). Antibiotic treatments have also been reported
to decrease the inflammatory reactions in acne lesions
(Akamatsu et al., 2003; Sapadin and Fleischmajer, 2006).
However, the use of these RAs and antibiotics in acne therapy
has been limited in acceptance because of adverse effects,
such as skin irritation and scaling, teratogenicity, and the
induction of bacterial resistance (Eady et al., 1994;
Toyoda and Morohashi, 1998; Krautheim and Gollnick,
2004). Therefore, novel anti-acne agents with not only anti-
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lipogenic and anti-inflammatory actions, but also with no or
less propensity for causing side effects, may be more
beneficial for the remission and/or cure of acne.
Flavonoids from medicinal plants exert various pharma-
cological effects in vivo and in vitro, including serving as
antioxidants, free radical scavenging, anti-inflammatory
activity, and have antitumorigenic and antitumor metastatic
activities (Robak and Gryglewski, 1988; Kawaii et al., 1999;
Sato et al., 2002; Lin et al., 2003). In addition, Seki and
Morohashi (1993) reported that wogonin, a flavonoid derived
from Japanese–Chinese traditional herbal medicines, inhibits
lipogenesis in hamster sebaceous glands. We previously
reported that nobiletin (5, 6, 7, 8, 30, 40-hexamethoxy
flavone), a major component in the juice of Citrus depressa
Hayata (Rutaceae), inhibits UVB-induced production of an
inflammatory mediator, prostaglandin E2, in human kerati-
nocytes, as well as hyperkeratinization in the epidermis of
mice (Tanaka et al., 2004). Furthermore, nobiletin has been
reported to inhibit the gene expression and production of
proinflammatory cytokines such as IL-1, IL-6, and tumor
necrosis factor a in lipopolysaccharide-stimulated mouse
macrophages (Lin et al., 2003). Therefore, we hypothesized
that the anti-inflammatory agent, nobiletin, may be effective
for remission of acne vulgaris.
In this study, we examined the effects of nobiletin on
sebum production and excretion as compared with RAs in
vivo and in vitro. Our results showed that nobiletin is a novel
anti-acne agent with unique therapeutic actions that not only
inhibits lipogenesis and cell proliferation in sebaceous
glands, but also facilitates the depletion of sebaceous lipids
by increasing sebum excretion.
RESULTS
Effects of topical application of nobiletin and atRA on
sebaceous and epidermal morphology, and sebum levels on the
skin surface
We first examined the effects of nobiletin (1 and 2%) (Tanaka
et al., 2004) on sebaceous glands and epidermis in hamsters
by comparing the effects with those produced by atRA
(0.2%), a well-known anti-acne agent (Krautheim and
Gollnick, 2004; Chivot, 2005). As shown in Figure 1, when
auricles were treated once a day with 50 ml of 2% nobiletin or
0.2% atRA for 14 days, the size of sebaceous glands (arrow
heads) in nobiletin- (panel b) or atRA-treated hamsters (panel
c) was found to decrease overall compared with that in the
hamsters receiving vehicle only (panel a, arrow heads).
Although the topical treatment of atRA was found to increase
epidermal thickness (Figure 1c vs 1a, asterisks), there was no
change in the nobiletin-treated epidermis (Figure 1b vs 1a,
asterisks). In addition, thin-layer chromatographic analysis of
sebum on the skin surface showed that levels of triacylgly-
cerols (TG), a major sebum component, decreased in both
2% nobiletin- and atRA-treated hamsters (Table 1).
Inhibition of DGAT-dependent TG synthesis and cell
proliferation by nobiletin and RAs in hamster sebocytes
To clarify the molecular mechanisms of the anti-acne actions
of nobiletin, we examined the regulation of TG synthesis by
this flavonoid and RAs in insulin-differentiated hamster
sebocytes, in which TG synthesis and intracellular lipid
droplet formation were augmented (Figure 2) (Akimoto
et al., 2005). Nobiletin was found to dose-dependently
decrease the level of intracellular TG, as did 13-cisRA
(Figure 2a) and atRA as well (data not shown, Sato et al.,
2001). In addition, nobiletin, 13-cisRA, and atRA were found
to decrease diacylglycerol acyltransferase (DGAT) activity in
the differentiated sebocytes (Figure 2b). Furthermore, the
proliferation of hamster sebocytes was found to be inhi-
bited by nobiletin, 13-cisRA, and atRA in a dose-dependent
manner (Table 2).
a
c
b
Figure 1. Effects of nobiletin and atRA on hamster sebaceous glands.
Auricles of hamsters were treated once a day (b) with 2% nobiletin (2.5 mmol)
or (c) 0.2% atRA (0.3 mmol) in 95% ethanol and 5% glycerol, and with the
vehicle solution alone (a) for 14 days. After the treatments, auricle tissues
were fixed and stained with hematoxylin and eosin as described in the text.
Arrowheads, sebaceous glands. Asterisks, epidermis. Bar, 200 mm.
Table 1. Decrease in the skin surface level of TG in
nobiletin- and atRA-treated hamsters
Treatments Concentrations
Relative amounts of TG on
the skin surface (% of
vehicle treated hamsters)
Vehicle — 100
Nobiletin 1% 108.277.4
2% 66.2722.5*
AtRA 0.2% 35.0729.3*
atRA, all-trans retinoic acid; TG, triacylglycerols.
TG on the skin surface of nobiletin (1 or 2%)- or atRA (0.2%)-treated
hamsters was extracted and quantified by thin layer chromatographic
analysis as described in the text.
The relative amounts of skin surface TG were expressed by taking
vehicle-treated hamsters as 100%.
Data are indicated as mean7SD from three individual extracts.
*Significantly different from vehicle-treated hamsters (Po0.05).
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Inhibitory actions of nobiletin on UVB-induced abnormal
sebaceous lipogenesis in hamsters
We considered that in vivo and in vitro acne models might be
useful to further evaluate the pharmacological efficacy of
nobiletin for acne therapy, but there are few established acne
models. As UVB has been reported to exhibit aberrant
functional and morphological changes in sebaceous and
pilosebaceous units, for example, sebaceous hyperplasia,
augmentation of sebum synthesis and accumulation, and
hypercornification of follicular keratinocytes (Lesnik et al.,
1992; Suh et al., 2002; Akitomo et al., 2003), we employed
UVB-irradiated hamsters and sebocytes to estimate the
anti-acne action of nobiletin against sebum production. As
shown in Figure 3, oil red O staining showed that sebum
accumulation was augmented in sebaceous glands and
follicular ducts in UVB (5.4 kJ/m2)-irradiated hamsters (panels
b vs a). When nobiletin was topically applied to the skin of
auricles after each UVB-irradiation for 7 days, the aberrant
sebum accumulation in sebaceous glands and follicular
ducts was found to be depressed (Figure 3c vs 3b). The level
of TG on the skin surface was found to increase in the
UVB-irradiated hamsters (2.1-fold), and the augmentation
was inhibited by nobiletin-treatment (Figure 4a). Moreover,
the DGAT activity was time-dependently increased by UVB
irradiation for 24 hours (data not shown), and the augmented
enzymic activity was dose-dependently suppressed by
nobiletin in the differentiated hamster sebocytes (Figure 4b),
suggesting that nobiletin inhibited the aberrant sebum
production by decreasing DGAT activity in UVB-irradiated
hamster sebaceous glands.
Nobiletin induces sebum excretion in a cAMP/PKA-dependent
manner
Although RAs have been reported to directly inhibit
sebum production in vivo and in vitro (Zouboulis et al.,
1991; Kim et al., 2000; Sato et al., 2001; Nelson et al., 2006),
there is little evidence whether or not abundantly accumu-
lated sebum in sebaceous glands might be excreted to the
skin surface by anti-acne agents. Therefore, we examined
the effect of nobiletin and RAs on sebum excretion in the
differentiated hamster sebocytes by measuring the extracel-
lular TG level. As shown in Figure 5a, nobiletin was found
to dose-dependently augment the TG level in the culture
medium. The extracellular TG level was also time-dependently
augmented by nobiletin for 24 hours, and the increased level
of TG was sustained for up to 48 hours (data not shown),
indicating that nobiletin depleted the accumulated sebum
along with the inhibition of TG synthesis in sebaceous glands.
However, there was no change in the extracellular TG level
in both 13-cisRA- and atRA-treated sebocytes (Figure 5b and
data not shown, respectively). Furthermore, we investigated
the involvement of intracellular cAMP in the nobiletin-
induced sebum excretion, because cAMP has been reported
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Figure 2. Nobiletin and RAs decrease the production of TG and DGAT
activity in insulin-treated hamster sebocytes. (a) Confluent hamster sebocytes
at the third passage were treated every 3 days with nobiletin (Nob) (16–64 mM)
or 13-cisRA (0.01–1 mM) in the presence of insulin (10 nM) for 12 days, and
then the intracellular levels of TG were measured as described in the text.
(b) Confluent hamster sebocytes at the third passage were treated with
nobiletin (Nob) (64 mM), 13-cisRA (1 mM), or atRA (1 mM) in the presence of
insulin (10 nM) for 6 days. The harvested cells were subjected to the
measurement of DGAT activity as described in the text. Data are indicated as
mean7SD of three dishes. ***Significantly different from untreated cells
(none) (Po0.001). # and ###significantly different from insulin-treated cells
(Po0.05 and 0.001, respectively).
Table 2. Inhibition of cell proliferation by nobiletin
and RAs in hamster sebocytes
Treatments
Concentrations
(lM)
Cell proliferation
( 103 d.p.m./well)
% Of
untreated cells
None 2.0370.20 100.0
Nobiletin 16 1.1070.25** 54.2
32 0.3670.07*** 17.7
64 0.1670.03*** 7.9
13-cisRA 0.01 1.5070.13** 73.9
0.1 0.6070.11*** 29.5
1 0.4970.02*** 24.1
atRA 0.01 1.8670.39 91.6
0.1 1.0270.20** 50.2
1 0.7670.10** 37.4
atRA, all-trans retinoic acid; 13-cisRA, 13-cis retinoic acid.
Hamster sebocytes at the third passage in 24-well multiplates were treated
every 3 days with nobiletin (16–64mM), 13-cisRA (0.01–1 mM), or atRA
(0.01–1 mM) for 12 days, and then [3H]thymidine (1 kBq/well) was added to
the cells for the last 3 h of the treatments as described in the text. Data are
indicated as mean7SD of four wells. ** and *** significantly different
from untreated cells (none) (Po0.01 and 0.001, respectively).
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to play a role as a possible second messenger for the
pharmacological actions of nobiletin (Nagase et al., 2005).
As shown in Figure 6a, nobiletin was found to increase
the intracellular cAMP level within 20 minutes in the dif-
ferentiated hamster sebocytes. Thereafter, the cAMP level
slightly decreased for 20–60 minutes, but was still significantly
higher than that in the untreated cells. In addition, cAMP levels
were dose-dependently increased in the nobiletin treatment
(Figure 6b). Moreover, nobiletin was found to activate
protein kinase A (PKA) in the differentiated hamster sebocytes
(Figure 6c). Similar sebum excretion and PKA activation was
reproduced by forskolin in the sebocytes (Figures 5c and 6c,
respectively). However, there was no change in the
intracellular cAMP level and PKA activity in the 13-cisRA-
treated sebocytes (Figure 6b and c, respectively).
Non-apoptotic PS exposure is associated with the
nobiletin-induced sebum excretion
Sebum secretion (or excretion) from sebaceous glands to
follicular ducts or the skin surface has been reported to be
regulated by a holocrine mechanism, which may include
sebocyte apoptosis (Wro´bel et al., 2003). We, therefore,
examined whether or not nobiletin-induced sebum excretion
might be associated with sebocyte apoptosis. Flow cyto-
metric analysis showed that nobiletin treatment augmented
the number of Annexin V-FITC-positive sebocytes, whereas
there was no change in the 13-cisRA and atRA-treated cells
a
b
c
Figure 3. Inhibition of sebum accumulation by nobiletin in sebaceous glands
and ducts from the UVB-irradiated hamsters. Auricles of hamsters were
treated once a day with 2% nobiletin (2.5 mmol) in 95% ethanol and 5%
glycerol or the vehicle solution alone after each UVB irradiation at 5.4 kJ/m2
for 7 days. After the treatments, the tissues were fixed and stained with oil red
O, indicating lipid accumulation in sebaceous glands and ducts. The tissues
were also counterstained with hematoxylin. (a–c), vehicle-, UVB plus vehicle-,
and UVB plus nobiletin-treated hamsters, respectively. Arrowheads,
sebaceous glands. Bars, (a and b) 200 mm and (c) 100 mm.
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Figure 4. Suppression of sebum production and DGAT activity by nobiletin
in UVB-irradiated hamsters and differentiated sebocytes. (a) Levels of TG on
the skin surface of UVB- and/or nobiletin-treated hamsters as described in
Figure 3 were measured by automatic thin-layer chromatography as described
in Table 1. Cont, vehicle-treated hamsters; UVB, UVB (5.4 kJ/m2) plus
vehicle-treated hamsters; and UVB þ Nob, UVB (5.4 kJ/m2) plus nobiletin
(64mM)-treated hamsters. (b) Confluent hamster sebocytes at the third passage
were treated every 3 days with insulin (10 nM) to complete the sebocytic
differentiation as described in the text. The differentiated cells were irradiated
with UVB (0.6 kJ/m2) and/or nobiletin (16–64 mM) for 24 hours, and then
DGAT activity in the cells was measured as described in Figure 2. Data are
indicated as mean7SD of three dishes. * and ***significantly different from
(a) vehicle-treated hamsters (Cont) or (b) differentiated control cells (Cont)
(Po0.05 and 0.001, respectively). # and ###significantly different from
UVB-irradiated hamsters (a) or sebocytes (b) (Po0.05 and 0.001,
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Figure 5. Augmentation of extracellular TG levels by nobiletin, 13-cisRA,
and forskolin in the differentiated hamster sebocytes. The differentiated
sebocytes at the third passage as described in Figure 4 were treated with
nobiletin (Nob) (a, 8–64mM and b and c, 64mM), (b) 13-cisRA (0.01–1mM), and
(c) forskolin (1–10mM) for 24 hours. The extracellular levels of TG were
measured as described in the text. The relative amounts of TG were expressed
by taking 64 mM nobiletin (Nob)-treated cells as 100%. Data are indicated
as mean7SD of three dishes. ** and ***significantly different from the
insulin-differentiated cells (Cont) (Po0.01 and 0.001, respectively).
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(Figure 7a–c), indicating that nobiletin, but not RAs, caused
phosphatidylserine (PS) externalization in the differentiated
sebocytes. Similar PS exposure to the cell surface was
observed in the forskolin-treated sebocytes (Figure 7d).
However, no DNA ladders were detected in the nobiletin-
treated sebocytes for 24 hours (inserted panel in Figure 7a,
lane 2) and further for up to 72 hours (data not shown),
whereas staurosporine, a broad-spectrum protein kinase
inhibitor and well-known apoptosis inducer (Bertrand et al.,
1994; Wro´bel et al., 2003), exhibited the DNA degradation
for 24 hours (inserted panel in Figure 7a, lane 3). Further-
more, the nobiletin-induced PS externalization was found to
be inhibited by a PKA inhibitor, H-89, in the differentiated
sebocytes (Figure 8a and b). Moreover, under the same
culture conditions, the nobiletin-augmented extracellular TG
level was found to decrease on treatment with H-89 in a
dose-dependent manner (Figure 8c).
DISCUSSION
Regarding lipid metabolism by flavonoids, quercetin, a
common dietary flavonoid, has been reported to show
an inhibitory activity on TG synthesis by decreasing DGAT
activity in cultured human intestinal CaCo-2 cells (Casaschi
et al., 2002). Cha et al. (2001) reported that a citrus flavonoid,
hesperetin, inhibits the activity of hepatic microsomal
phosphatidate phosphohydrolase, which is a rate-limiting
enzyme for TG synthesis in hepatocytes, and thereby causes
the reduction of hepatic TG content in rats fed diets with 1%
orotic acid. In this study, we demonstrated that topical
application of nobiletin depressed the skin surface TG level.
In addition, we learned that the decrease in DGAT activity in
differentiated hamster sebocytes was associated with the
suppression of TG production. Similarly, topical application
of atRA also decreased the levels of skin surface TG as well as
sebaceous gland size. As was true for nobiletin, both atRA
and 13-cisRA inhibited DGAT activity in differentiated
hamster sebocytes. As TG is a major component of sebum
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Figure 6. Nobiletin increases the intracellular levels of cAMP and PKA
activity in differentiated hamster sebocytes. The differentiated hamster
sebocytes as described in Figure 4 were treated (a) with nobiletin (Nob)
(64mM) for 10–60 minutes, and (b) with nobiletin (16–64mM), or 13-cisRA
(0.1 and 1 mM) for 10 minutes. The harvested cells were subjected to the
measurement of intracellular cAMP as described in the text. (a) The relative
amounts of intracellular cAMP in nobiletin treatment (closed squares) were
expressed taking each control cell (closed diamonds) as 100% at indicated
time points. Data are indicated as mean7SD of three dishes. ***Significantly
different from control cells (Po0.001). (b) The amounts of intracellular cAMP
in nobiletin- or 13-cisRA-treated cells were measured and data are indicated
as mean7SD of three dishes. * and **significantly different from untreated
cells (Cont) (Po0.05 and 0.01, respectively). (c) The differentiated hamster
sebocytes at the third passage as described in Figure 4 were treated with
nobiletin (64 mM), 13-cisRA (1 mM), or forskolin (1 mM) for 30 minutes. The
harvested cells were subjected to Western blot analysis for PKA-dependent
phosphorylated protein (arrow) as described in the text.
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Figure 7. Augmentation of the cell surface exposure of phosphatidylserine
by nobiletin in the differentiated hamster sebocytes. The differentiated
hamster sebocytes as described in Figure 4 were treated with (a) nobiletin
(Nob) (64mM), (b) 13-cisRA (1 mM), (c) atRA (1 mM), and (d) forskolin (Fork)
(1 mM) for 24 hours, and then stained with Annexin V-FITC for 5 minutes as
described in the text. The number of Annexin V-positive cells was measured
by flow cytometric analysis. Cont, differentiated control cells. Inserted panel
in (a) DNA fragmentation in the differentiated hamster sebocytes treated
without (lane 1) or with nobiletin (64 mM) (lane 2), or with staurosporine (5 mM)
(lane 3) for 24 hours.
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(Sato et al., 2001), and a nutritional element for P. acnes
leading to the development of acne vulgaris (Bojar and
Holland, 2004; Pawin et al., 2004), these results strongly
suggested that, like RAs, nobiletin might be an effective
agent for acne therapy by virtue of directly inhibiting TG
production both in vivo and in vitro. Moreover, the topical
application of atRA, but not nobiletin, augmented epidermal
thickness in the hamsters. Taken together with our previous
studies (Minagawa et al., 2001; Tanaka et al., 2004) and a
recent report by Rittie et al. (2006), we suggest the possibility
that acne therapy with nobiletin may decrease or avoid
adverse effect, at least scaling seen with RA treatment.
Many investigators have reported experimental and
clinical evidence regarding the pathophysiology of acne
and acne therapy (Bojar and Holland, 2004; Krautheim and
Gollnick, 2004; Schaller et al., 2005; Trivedi et al., 2006), but
there are few in vivo acne models for the estimation of
the potential efficacy of novel anti-acne agents. Sebaceous
glands in acne lesions have been characterized not only by
excess lipogenesis but also by sebaceous enlargement owing
to accumulating sebum (Pawin et al., 2004). In addition,
hyperkeratinization of the follicular wall has been reported
to participate in microcomedo development at the primary
site (Bojar and Holland, 2004). We hypothesized that
UVB-irradiation might mimic aberrant sebum production
and sebaceous enlargement seen in acne pathology in vivo
(Lesnik et al., 1992; Suh et al., 2002; Akitomo et al., 2003).
Indeed, the augmentation of skin surface lipid levels and
sebum accumulation in sebaceous glands and ducts, and
sebaceous enlargement were all observed in our in vivo
model of UVB-irradiated hamsters. In addition, the topical
application of nobiletin prevented these aberrant changes
in sebaceous glands in the UVB-irradiated hamsters. Further-
more, we determined that the suppression of TG production
by nobiletin was associated with a decrease in the UVB-
augmented DGAT activity in the differentiated hamster
sebocytes. We also demonstrated that nobiletin suppressed
sebocyte proliferation, suggesting that nobiletin may interfere
with UVB-induced sebaceous gland enlargement. Taken
together with our previous reports that nobiletin exerts anti-
inflammatory actions (Lin et al., 2003; Tanaka et al., 2004),
we propose that nobiletin is a useful candidate as a
novel anti-acne agent with antilipogenic, antiproliferative,
anticomedogenic, and anti-inflammatory actions against
sebaceous glands, pilosebaceous units, and infiltrated in-
flammatory cells in acne lesions.
As sebaceous glands in acne lesions accumulate abundant
sebum along with the augmentation of lipogenesis (Pawin
et al., 2004), it seems to be important to stimulate promptly
the excretion of accumulated sebum in follicular ducts or on
the skin surface in concomitant with the inhibition of
sebaceous lipogenesis. In this study, we found early evidence
that nobiletin positively excreted TG to culture medium in the
differentiated hamster sebocytes within 24 hours, whereas
there was no TG excretion in either 13-cisRA- or atRA-treated
cells. In addition, the nobiletin-mediated TG excretion
was initiated by a transient increase in intracellular cAMP
level and, thereafter, PKA activation. Similar TG excretion
was reproduced in the forskolin-treated differentiated sebo-
cytes. However, neither 13-cisRA nor atRA augmented the
intracellular cAMP level and PKA activity in the hamster
sebocytes. To date, some reports have shown an increase
in intracellular cAMP level by plant flavonoids such as
quercetin, fisetin, and genistein in adipocytes from rats
(Kuppusamy and Das, 1994; Szkudelska et al., 2000) and
mice (Harmon and Harp, 2001). Recently, Nagase et al.
(2005) reported that nobiletin in combination with forskolin
augments PKA activity by increasing cAMP level in PC12D
cells, a rat pheochromocytoma cell line. Taken together, it is
suggested that the transient increase in cAMP level and the
sequential PKA activation are involved in the nobiletin-
mediated sebum excretion.
Sebum secretion is generally considered to be regulated by
a holocrine mechanism, which may contain sebaceous
apoptosis (Wro´bel et al., 2003). However, there is little
evidence dealing with the regulation of sebum holocrine
secretion, and especially the question of whether or not
sebocyte apoptosis may be requisite for the holocrine
mechanism. In this study, flow cytometric analysis using
Annexin V-FITC revealed that nobiletin facilitated cell surface
exposure of PS in the differentiated hamster sebocytes.
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Figure 8. Inhibition of nobiletin-induced cell surface exposure of
phosphatidylserine and TG excretion by a PKA inhibitor, H-89, in the
differentiated hamster sebocytes. (a and b) The differentiated hamster
sebocytes as described in Figure 4 were pretreated with or without H-89
(50mM) for 1 hour, and then treated with nobiletin (Nob) (64mM) for another
24 hours. The harvested cells were stained by Annexin V-FITC for 5 minutes,
and the number of Annexin V-positive cells was then measured by flow
cytometric analysis as described in the text. Three independent experiments
were highly reproducible and typical data are shown. (c) The cells were
treated with nobiletin (64 mM) and H-89 (20–50 mM) as described above, and
then the harvested culture media were subjected to measurement of TG. Data
are indicated as mean7SD of three dishes. ***Significantly different from the
differentiated control cells (Cont) (Po0.001). ##,###significantly different from
the nobiletin (64 mM)-treated cells (Po0.01 and 0.001, respectively).
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However, neither 13-cisRA nor atRA induced the PS
externalization, in keeping with the previous report by
Wro´bel et al. (2003). Although Annexin V is an indicator
for cell apoptosis induction (Koopman et al., 1994; Wro´bel
et al., 2003), there was no DNA ladder detected in the
nobiletin-treated sebocytes, even for as long as 72 hours. In
addition, we confirmed that the PS exposure was reversible
by changing the fresh culture medium for another 24 hours
after pretreating the cells with nobiletin for 24 hours in the
differentiated sebocytes (data not shown). Furthermore, we
also confirmed that there were no propidium iodide-positive
signals in the nobiletin-treated sebocytes by immunocyto-
chemical staining and flow cytometric analyses, whereas the
staurosporine (5mM)-treated cells were stained with propi-
dium iodide (data not shown). Thus, nobiletin-induced
sebum excretion may be associated with the PS translocation
to the plasma membrane outer leaflet in sebocytes, which
may differ from the holocrine mechanism and cell death
related to sebaceous apoptosis.
Extracellular exposure of PS has been reported to be
involved in physiological events such as myotube formation
(van den Eijnde et al., 2001) and sperm capacitation (Gadella
and Harrison, 2002), which are independent of apoptosis.
A recent report by Elliott et al. (2005) showed that apoptosis-
independent PS externalization modulates several functions,
including Naþ and Ca2þ uptake through P2X7 cation
channel, and reversal of the activity of P-glycoprotein, the
multidrug transporter, in T lymphocytes. Furthermore,
Smith et al. (2002) reported that the cAMP analog, 8-Br-
cAMP, induces PS externalization and lipid efflux via ABCA1
in RAW264.7. Regarding mechanisms of PS externalization
in sebocytes, we suggest that the activation of cAMP-
dependent PKA is at least a principal signal pathway for PS
exposure leading to sebum excretion. Further experiments are
needed to clarify how cAMP/PKA activation causes the PS
externalization and whether nobiletin could modulate func-
tions of aminophospholipid transporters such as floppases
and scramblase (Zhou et al., 1997; Bevers et al., 1999).
In conclusion, we demonstrated that nobiletin inhibited
sebaceous lipogenesis and enlargement and hyperkeratiniza-
tion in the epidermis and follicular wall of hamsters, both in
vivo and in vitro. Furthermore, we have supplied the early
evidence that nobiletin facilitates the excretion of sebum
accumulated in differentiated sebocytes via a molecular
mechanism that includes non-apoptotic PS externalization
through a cAMP/PKA-dependent pathway. Taken together
with our previous studies of the anti-inflammatory actions of
nobiletin (Lin et al., 2003; Tanaka et al., 2004), this early
evidence shows that nobiletin is likely to be a unique anti-
acne agent with not only antilipogenic and antiproliferative
actions for sebocytes, but also the acceleration of sebum
excretion to deplete lipids in sebaceous glands.
MATERIALS AND METHODS
Histochemical analysis
Auricles of 5-week-old male golden hamsters were topically treated
once a day for 14 days with a 50-ml solution of 1 and 2% nobiletin
(1.25 and 2.5 mmol) or 0.2% atRA (0.3 mmol) (Sigma Chemical,
St Louis, MO) in 95% ethanol and 5% glycerol, or with the same
volume of vehicle alone according to our previous report (Tanaka
et al., 2004) with some modifications. After the treatments, tissues
were fixed with 4% paraformaldehyde, embedded in paraffin, and
their sections were subjected to Mayer’s hematoxylin-eosin staining
(Wako Pure Chemicals, Osaka, Japan). After terminating the
staining, tissue secretions were washed with ethanol and xylene
and then viewed with a light microscope furnished with a digital
camera (Olympus Optical, Tokyo, Japan). Epidermal thickness
in 10 randomly chosen areas per section was measured under the
microscope at 100-fold magnification. The animals had free access
to food and water according to the Guidelines of Experimental
Animal Care issued by the Prime Minister’s Office of Japan. The
experimental protocol was approved by the Committee of Animal
Care and Use of Tokyo University of Pharmacy and Life Sciences.
Oil red O staining
Skin from hamster auricles was snap-frozen in liquid nitrogen. The
frozen tissue sections (8mm thickness) were incubated in 60%
isopropanol after washing with distilled H2O. Tissue sections were
stained with 0.3% oil red O (Sigma) in a solution of isopropanol and
distilled H2O (3:2, vol:vol) at 371C for 15 minutes, and were then
viewed with a light microscope furnished with a digital camera.
Sections were also counterstained with Mayer’s hematoxylin
solution (Wako).
Cell culture and treatments
Hamster sebocytes were established from sebaceous glands of
auricles of 5-week-old male golden hamsters as described previously
(Sato et al., 2001). Sebocytes (2.35 104 cells/cm2) in DMEM/Ham’s
F12 medium (1:1) (DMEM/F12) (Invitrogen, Carlsbad, CA) supple-
mented with 6% heat-denatured fetal bovine serum (JRH Bioscience,
Tokyo, Japan), 2% human serum (ICN Biochemicals, Costa Mesa,
CA), 0.68 mM L-glutamine (Invitrogen), and recombinant human
epidermal growth factor (10 nM) (Progen Biotechnik GmbH,
Heidelberg, Germany) were plated onto 35 or 100-mm diameter
culture dishes (Becton Dickinson, Tokyo, Japan) for 24 hours to
achieve complete cell adhesion. For the portion of the study dealing
with sebum synthesis, the cells were treated every 3 days with
nobiletin (16–64 mM), 13-cisRA (0.01–1mM) (Sigma), or atRA
(0.01–1 mM) in the presence or absence of insulin (10 nM) (Sigma),
in DMEM/F12 supplemented with heat-denatured fetal bovine
serum, human serum, and L-glutamine for up to 12 days according
to previous studies (Akimoto et al., 2005 and Iwata et al., 2005). For
the measurement of sebum excretion, the cells were pretreated
with insulin (10 nM) in DMEM/F12 supplemented with heat-
denatured fetal bovine serum, human serum, and L-glutamine to
accumulate intracellular lipid droplets (termed, differentiated
sebocytes), and then treated with nobiletin, 13-cisRA, forskolin
(Sigma), and/or a PKA inhibitor, H-89 (BIOMOL, Plymouth
Meeting, PA), in the medium without serum for up to 72 hours.
In this series of experiments, hamster sebocytes were used at up to
the third passage level.
UVB irradiation
UV has been reported to cause abnormal sebum production and
sebaceous enlargement (Lesnik et al., 1992; Suh et al., 2002;
Akitomo et al., 2003). Therefore, to further evaluate the anti-acne
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activity of nobiletin in vivo, we established UVB-irradiated hamster
sebocyte models in vivo and in vitro. Briefly, the skin of 3-week-old
male golden hamsters was treated, as described above, once a day
with nobiletin or vehicle after each UVB irradiation (5.4 kJ/m2) for 7
days (Tanaka et al., 2004). The insulin-differentiated hamster
sebocytes were irradiated with UVB (0.6 kJ/m2) (Tanaka et al.,
2004), and then cultured for 24 hours. The UVB irradiation was
created using a Toshiba FL20S fluorescent sunlamp (Toshiba, Tokyo,
Japan), emitting rays between 275 and 375 nm with a peak emission
of 313 nm. The radiance was measured by a UV Indicator MI-340
(Eko, Tokyo, Japan) as described previously (Tanaka et al., 2004).
TG measurement
TG levels in sebum from the skin surface of hamster auricles were
analyzed by automatic thin-layer chromatography, Iatroscan (Iatron
Laboratories, Tokyo, Japan), as described previously (Sato et al.,
2001). Briefly, the auricles were wiped with acetone-impregnated
cotton, and then the sebum on the skin surface was extracted twice
with 50 ml of acetone for 30 seconds using stainless cups, 1 hour after
the wiping. The sebum extracts were subjected to Iatroscan and the
amount of TG was calculated using an internal control concomi-
tantly performed using authentic cholesterol acetate (2mg) (Doosan
Serdary Research Laboratories, Englewood Cliffs, NJ). Otherwise,
sonicated cell lysates and the harvested culture media were used to
measure the intracellular and extracellular levels of TG using
Liquitech TG-II (Roche Diagnostics, Tokyo, Japan) according to the
manufacturer’s instructions. The amount of TG was calculated using
an authentic trioleinate-standard solution (0.6 mg/ml). The intracel-
lular DNA content was measured using authentic salmon sperm
DNA (6.25–100 mg/ml) and 3,5-diaminobenzoic acid dihydrochlor-
ide (Sigma) as described previously (Sato et al., 2001).
Measurement of DGAT activity
DGAT activity in hamster sebocytes treated with nobiletin, 13-cisRA,
atRA, or UVB was measured using 1,2-dioleoyl glycerol (Cayman
Chemical, Ann Arbor, MI), and [14C]palmitoyl-CoA (Amersham
Biosciences, Tokyo, Japan) as described previously (Iwata et al.,
2005).
Cell proliferation assay
When hamster sebocytes in 24-well multiplates were treated every 3
days with nobiletin, 13-cisRA, or atRA for a total of 12 days,
[3H]thymidine (1 kBq/well) (Amersham Biosciences) was added to
the cells for the last 3 hours of the treatments. The radioactivity of
[3H]thymidine incorporated into the DNA was measured by a liquid
scintillation counter (Aloka, Tokyo, Japan) after lysing the cells, and
recorded as the cell proliferative activity.
Measurement of intracellular cAMP levels
Hamster sebocytes were treated with nobiletin or 13-cisRA for up to
60 minutes. The harvested cells were subjected to the measurement
of intracellular cAMP levels via a cAMP enzyme immunoassay kit
(Cayman Chemical) according to the manufacturer’s instructions.
Measurement of PKA activity
Cells were treated with nobiletin, 13-cisRA, or forskolin for
30 minutes, and then homogenized in Ca2þ - and Mg2þ -free
phosphate-buffered saline supplemented with 1% Nonidet P-40,
0.1%. SDS, 0.5 mM phenylmethylsulfonyl fluoride, 5mM pepstatin,
10 mM leupeptin, and 1 mM sodium orthovanadate. After centrifuga-
tion at 15,000 g for 20 minutes at 41C, the resultant supernatant
was collected as the cytosol fraction and used for the analysis
of kinase activity. Briefly, aliquots (20 mg) of the cytosol protein
were analyzed by Western blotting using a specific rabbit anti-
body against phospho-(Ser/Thr) PKA substrate (Cell Signaling
Technology, Danvers, MA) under nonreducing conditions. Immuno-
reactive phosphorylated PKA substrates were detected with en-
hanced chemiluminescence Western-blotting detection reagents
(Amersham Bioscience) after being complexed with horse-
radish peroxidase-conjugated antirabbit IgG (Sigma). Relative
amounts of the immunoreactive proteins were quantified by
densitometric scanning using an Image Analyzer LAS-1000 plus
(Fuji Film, Tokyo, Japan).
Flow cytometric analysis
Insulin-differentiated hamster sebocytes were treated with nobiletin,
13-cisRA, or forskolin for 24 hours. In addition, the cells were
pretreated with a PKA inhibitor, H-89, for 1 hours, and then treated
with nobiletin for another 24 hours. After the treatments, the cells
were stained with Annexin V-FITC (10mg/ml) (Medical Biological
Laboratories, Nagoya, Japan) for 5 minutes. The cells were harvested
with 0.25% trypsin and 0.02% EDTA in Ca2þ - and Mg2þ -free
phosphate-buffered saline and then resuspended in the culture
medium. The number of Annexin V-positive cells was measured via
a FACScan flow cytometer (Becton Dickinson, Tokyo, Japan).
DNA fragmentation assay
Sebocytes treated with nobiletin or staurosporine (1mM) (Sigma) were
lysed in Tris-EDTA (TE) buffer (50 mM Tris-HCl (pH 7.5) and 10 mM
EDTA) containing 0.5% sodium N-lauroylsarcosinate, and then
incubated with RNase (500 mg/ml) for 30 minutes at 501C. After
RNase treatment, the cell lysates were incubated for 24 hours at
–201C with proteinase K (500 mg/ml) for 30 minutes at 501C, and after
which the DNA in the lysates was precipitated with 50%
isopropanol solution containing 0.5 M NaCl. Precipitated DNA was
resuspended in TE buffer and then electrophoresed on 1% agarose
gels. Ethidium bromide-stained gels were photographed using a UV
transilluminator as the sole light source.
Statistical analysis
Data are presented as mean7SD, and were analyzed by a one-way
analysis of variance and by the Fisher test for multiple comparisons.
A value of Po0.05 was considered to indicate a statistically
significant difference.
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